Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T18:00:44.063Z.
Calculation as of: 2026-10-06T18:00:44.063Z.
Quote observation: 2026-10-06T18:00:17.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9f7ef7d03019e78f4201474ef0c74f9c2a497de6c29d743f28e52983e243880
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2025-05-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
EV/SALES RATIO AVG TTM
1.20x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.08B
EV/Sales Ratio
N/A
TTM Avg
1.20x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.09B
EV/Sales Ratio
809.38x
TTM Avg
1123.66x
3Y Avg
904.58x
5Y Avg
368.85x
Market Cap
$3.03B
EV/Sales Ratio
6.71x
TTM Avg
9.31x
3Y Avg
10.36x
5Y Avg
140.89x
Market Cap
$3.19B
EV/Sales Ratio
5.07x
TTM Avg
6.76x
3Y Avg
15.91x
5Y Avg
14.09x
Market Cap
$2.80B
EV/Sales Ratio
4.77x
TTM Avg
7.37x
3Y Avg
10.06x
5Y Avg
14.84x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.08B | N/A | 1.20x | N/A | N/A |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | 809.38x | 1123.66x | 904.58x | 368.85x |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.03B | 6.71x | 9.31x | 10.36x | 140.89x |
| Enliven Therapeutics, Inc. (ELVN)vs › | $2.99B | N/A | N/A | N/A | N/A |
| Tarsus Pharmaceuticals, Inc. (TARS)vs › | $3.19B | 5.07x | 6.76x | 15.91x | 14.09x |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.84B | N/A | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.33B | N/A | N/A | N/A | N/A |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.35B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 4.77x | 7.37x | 10.06x | 14.84x |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 4.72x | 3.13x | 3.31x | 5.18x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2025-05-08 | 2.73x |
| 2025-05-07 | 2.96x |
| 2025-05-06 | 2.79x |
| 2025-05-05 | 3.18x |
| 2025-05-02 | 3.31x |
| 2025-05-01 | 3.17x |
| 2025-04-30 | 3.15x |
| 2025-04-29 | 2.98x |
| 2025-04-28 | 3.07x |
| 2025-04-25 | 3.34x |
| 2025-04-24 | 3.25x |
| 2025-04-23 | 3.11x |
| 2025-04-22 | 3.00x |
| 2025-04-21 | 2.46x |
| 2025-04-17 | 2.26x |
| 2025-04-16 | 2.14x |
| 2025-04-15 | 2.18x |
| 2025-04-14 | 2.20x |
| 2025-04-11 | 2.00x |
| 2025-04-10 | 1.88x |
| 2025-04-09 | 1.88x |
| 2025-04-08 | 1.74x |
| 2025-04-07 | 1.85x |
| 2025-04-04 | 1.83x |
| 2025-04-03 | 1.89x |
| 2025-04-02 | 2.10x |
| 2025-04-01 | 1.76x |
| 2025-03-31 | 1.92x |
| 2025-03-28 | 2.01x |
| 2025-03-27 | 2.18x |
| 2025-03-26 | 2.13x |
| 2025-03-25 | 2.10x |
| 2025-03-24 | 2.10x |
| 2025-03-21 | 2.00x |
| 2025-03-20 | 2.07x |
| 2025-03-19 | 2.00x |
| 2025-03-18 | 1.99x |
| 2025-03-17 | 2.08x |
| 2025-03-14 | 1.99x |
| 2025-03-13 | 2.02x |
| 2025-03-12 | 2.21x |
| 2025-03-11 | 2.07x |
| 2025-03-10 | 1.88x |
| 2025-03-07 | 2.18x |
| 2025-03-06 | 1.97x |
| 2025-03-05 | 1.77x |
| 2025-03-04 | 0.69x |
| 2025-03-03 | 0.69x |
| 2025-02-28 | 0.78x |
| 2025-02-27 | 0.74x |
| 2025-02-26 | 0.76x |
| 2025-02-25 | 0.71x |
| 2025-02-24 | 0.69x |
| 2025-02-21 | 0.79x |
| 2025-02-20 | 0.87x |
| 2025-02-19 | 0.87x |
| 2025-02-18 | 0.88x |
| 2025-02-14 | 0.94x |
| 2025-02-13 | 0.89x |
| 2025-02-12 | 0.87x |
| 2025-02-11 | 0.83x |
| 2025-02-10 | 0.94x |
| 2025-02-07 | 0.96x |
| 2025-02-06 | 0.95x |
| 2025-02-05 | 0.93x |
| 2025-02-04 | 0.90x |
| 2025-02-03 | 0.83x |
| 2025-01-31 | 0.91x |
| 2025-01-30 | 0.86x |
| 2025-01-29 | 0.85x |
| 2025-01-28 | 0.84x |
| 2025-01-27 | 0.86x |
| 2025-01-24 | 0.90x |
| 2025-01-23 | 0.88x |
| 2025-01-22 | 0.85x |
| 2025-01-21 | 0.84x |
| 2025-01-17 | 0.90x |
| 2025-01-16 | 0.86x |
| 2025-01-15 | 0.82x |
| 2025-01-14 | 0.73x |
| 2025-01-13 | 0.75x |
| 2025-01-10 | 0.86x |
| 2025-01-08 | 0.95x |
| 2025-01-07 | 0.98x |
| 2025-01-06 | 1.01x |
| 2025-01-03 | 1.09x |
| 2025-01-02 | 1.00x |
| 2024-12-31 | 0.96x |
| 2024-12-30 | 0.98x |
| 2024-12-27 | 0.99x |
| 2024-12-26 | 1.06x |
| 2024-12-24 | 1.03x |
| 2024-12-23 | 1.06x |
| 2024-12-20 | 1.05x |
| 2024-12-19 | 1.02x |
| 2024-12-18 | 1.01x |
| 2024-12-17 | 1.13x |
| 2024-12-16 | 1.10x |
| 2024-12-13 | 1.08x |
| 2024-12-12 | 1.18x |
| 2024-12-11 | 1.16x |
| 2024-12-10 | 1.21x |
| 2024-12-09 | 1.34x |
| 2024-12-06 | 1.43x |
| 2024-12-05 | 1.37x |
| 2024-12-04 | 1.47x |
| 2024-12-03 | 1.50x |
| 2024-12-02 | 1.57x |
| 2024-11-29 | 1.57x |
| 2024-11-27 | 1.64x |
| 2024-11-26 | 1.54x |
| 2024-11-25 | 1.61x |
| 2024-11-22 | 1.47x |
| 2024-11-21 | 1.45x |
| 2024-11-20 | 1.46x |
| 2024-11-19 | 1.46x |
| 2024-11-18 | 1.48x |
| 2024-11-15 | 1.30x |
| 2024-11-14 | 1.39x |
| 2024-11-13 | 1.62x |
| 2024-11-12 | 1.81x |
| 2024-11-11 | 2.08x |
| 2024-11-08 | 1.97x |
| 2024-11-07 | 1.25x |
| 2024-11-06 | 1.18x |
| 2024-11-05 | 1.08x |
| 2024-11-04 | 1.06x |
| 2024-11-01 | 1.04x |
| 2024-10-31 | 0.99x |
| 2024-10-30 | 0.96x |
| 2024-10-29 | 0.91x |
| 2024-10-28 | 0.97x |
| 2024-10-25 | 0.97x |
| 2024-10-24 | 0.88x |
| 2024-10-23 | 0.89x |
| 2024-10-22 | 0.79x |
| 2024-10-21 | 0.82x |
| 2024-10-18 | 0.85x |
| 2024-10-17 | 0.65x |
| 2024-10-16 | 0.69x |
| 2024-10-15 | 0.66x |
| 2024-10-14 | 0.57x |
| 2024-10-11 | 0.57x |
| 2024-10-10 | 0.55x |
| 2024-10-09 | 0.53x |
| 2024-10-08 | 0.50x |
| 2024-10-07 | 0.46x |
| 2024-10-04 | 0.47x |
| 2024-10-03 | 0.43x |
| 2024-10-02 | 0.45x |
| 2024-10-01 | 0.46x |
| 2024-09-30 | 0.50x |
| 2024-09-27 | 0.46x |
| 2024-09-26 | 0.49x |
| 2024-09-25 | 0.47x |
| 2024-09-24 | 0.44x |
| 2024-09-23 | 0.42x |
| 2024-09-20 | 0.47x |
| 2024-09-19 | 0.42x |
| 2024-09-18 | 0.42x |
| 2024-09-17 | 0.42x |
| 2024-09-16 | 0.36x |
| 2024-09-13 | 0.36x |
| 2024-09-12 | 0.33x |
| 2024-09-11 | 0.34x |
| 2024-09-10 | 0.37x |
| 2024-09-09 | 0.33x |
| 2024-09-06 | 0.30x |
| 2024-09-05 | 0.26x |
| 2024-09-04 | 0.24x |
| 2024-09-03 | 0.25x |
| 2024-08-30 | 0.26x |
| 2024-08-29 | 0.24x |
| 2024-08-28 | 0.24x |
| 2024-08-27 | 0.24x |
| 2024-08-26 | 0.26x |
| 2024-08-23 | 0.27x |
| 2024-08-22 | 0.26x |
| 2024-08-21 | 0.27x |
| 2024-08-20 | 0.27x |
| 2024-08-19 | 0.26x |
| 2024-08-16 | 0.24x |
| 2024-08-15 | 0.25x |
| 2024-08-14 | 0.24x |
| 2024-08-13 | 0.21x |
| 2024-08-12 | 0.21x |
| 2024-08-09 | 0.19x |
| 2024-04-10 | 0.01x |
| 2024-04-09 | 0.05x |
| 2024-04-08 | 0.05x |
| 2024-04-05 | 0.04x |
| 2024-04-04 | 0.04x |
| 2024-04-03 | 0.04x |
| 2024-04-02 | 0.04x |
| 2024-04-01 | 0.06x |
| 2024-03-28 | 0.08x |
| 2024-03-27 | 0.09x |
| 2024-03-26 | 0.06x |
| 2024-03-25 | 0.06x |
| 2024-03-22 | 0.06x |
| 2024-03-21 | 0.09x |
| 2024-03-20 | 0.10x |
| 2024-03-19 | 0.10x |
| 2024-03-18 | 0.08x |
| 2024-03-15 | 0.15x |
| 2024-03-14 | 0.14x |
| 2024-03-13 | 0.19x |
| 2024-03-12 | 0.19x |
| 2024-03-11 | 0.25x |
| 2024-03-08 | 0.17x |
| 2024-03-07 | 3.01x |
| 2024-03-06 | 3.03x |
| 2024-03-05 | 2.99x |
| 2024-03-04 | 3.04x |
| 2024-03-01 | 2.96x |
| 2024-02-29 | 2.99x |
| 2024-02-28 | 3.12x |
| 2024-02-27 | 3.02x |
| 2024-02-26 | 2.76x |
| 2024-02-23 | 2.77x |
| 2024-02-22 | 3.95x |
| 2024-02-21 | 3.19x |
| 2024-02-20 | 3.09x |
| 2024-02-16 | 3.32x |
| 2024-02-15 | 3.20x |
| 2024-02-14 | 3.13x |
| 2024-02-13 | 3.10x |
| 2024-02-12 | 3.41x |
| 2024-02-09 | 3.38x |
| 2024-02-08 | 3.22x |
| 2024-02-07 | 3.14x |
| 2024-02-06 | 3.25x |
| 2024-02-05 | 3.18x |
| 2024-02-02 | 3.30x |
| 2024-02-01 | 3.48x |
| 2024-01-31 | 3.35x |
| 2024-01-30 | 3.26x |
| 2024-01-29 | 3.30x |
| 2024-01-26 | 3.20x |
| 2024-01-25 | 3.20x |
| 2024-01-24 | 2.96x |
| 2024-01-23 | 3.02x |
| 2024-01-22 | 3.04x |
| 2024-01-19 | 3.11x |
| 2024-01-18 | 3.08x |
| 2024-01-17 | 3.13x |
| 2024-01-16 | 3.24x |
| 2024-01-12 | 3.30x |
| 2024-01-11 | 3.40x |
| 2024-01-10 | 3.39x |
| 2024-01-09 | 3.44x |
| 2024-01-08 | 3.56x |
| 2024-01-05 | 3.55x |
| 2024-01-04 | 3.50x |
| 2024-01-03 | 3.35x |
| 2024-01-02 | 3.11x |
| 2023-12-29 | 3.05x |
| 2023-12-28 | 3.05x |
| 2023-12-27 | 3.00x |
| 2023-12-26 | 2.93x |
Showing the most recent 260 of 540 data points. The chart above shows the full history.
